55
Participants
Start Date
February 28, 1997
Primary Completion Date
February 28, 2002
Study Completion Date
February 28, 2002
chemotherapy
gemtuzumab ozogamicin
New York Presbyterian Hospital - Cornell Campus, New York
Long Island Jewish Medical Center, New Hyde Park
University of Pennsylvania Cancer Center, Philadelphia
Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore
Sylvester Cancer Center, University of Miami, Miami
University of Chicago Cancer Research Center, Chicago
University of Texas - MD Anderson Cancer Center, Houston
Arizona Cancer Center, Tucson
Beckman Research Institute, City of Hope, Duarte
Fred Hutchinson Cancer Research Center, Seattle
New England Medical Center Hospital, Boston
University of Michigan Comprehensive Cancer Center, Ann Arbor
University of Nebraska Medical Center, Omaha
Lead Sponsor
Pfizer
INDUSTRY